参考文献/References:
[1] Makrilia N,Lappa T,Xyla V,et al.The role of angiogenesis in solid tumours:an overview.Eur J Intern Med,2009,20(7):663-671.
[2] Baluk P,Hashizume H,McDonald DM,Cellular abnormalities of blood vessels as targets in cancer.Curr Opin Genet Dev,2005,15(1):102-111.
[3] Nagy JA,Chang SH,Shih SC,et al.Heterogeneity of the tumor vas-culature.Semin Thromb Hemost,2010,36(3):321-331.
[4] Hlatky L,Hahnfeldt P,Folkman J.Clinical application of antiangio-genic therapy:microvessel density,what it does and doesn’t tell us.J Natl Cancer Inst,2002,94(12):883-893.
[5] Tozer GM.Measuring tumour vascular response to anti vascular and antiangiogenic drugs.Br J Radiol,2003,76Spec 1:S23-35.
[6] Ma SH,Le HB,Jia BH,et al.Peripheral pulmonary nodules:rela-tionship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.BMC Cancer,2008,8:186.
[7] Huo T,Du X,Zhang S,et al.Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.Eur J Radiol,2010,73(2):420-427.
[8] Cosgrove D,Lassau N.Assessment of tumour angiogenesis using contrast-enhanced ultrasound.J Radiol,2009,90(1 Pt 2):156-164.
[9] Jin B,Wang D,Lewandowski RJ,et al.Chemoembolization end-points:effect on survival among patients with hepatocellular carci-noma.AJR Am J Roentgenol,2011,196(4):919-928.
[10] Jin ZH,Furukawa T,Claron M,et al.Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c (-RGDfK-) 4[J/OL].Angiogenesis,2012[2012-08-12].http://www.springerlink.eom/contenl/71j60kv24q230p42.[published online ahead of print May 29,2012].
[11] Yang BW,Liang Y,Xia JL,et al.Biological characteristics of fluo-rescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.Eur J Gastroenterol Hepatol,2008,20(11):1077-1084.
[12] Zhou SA,Brahme A.Development of phase-contrast X-ray imaging techniques and potential medical applications.Phys Med,2008,24(3):129-148.
[13] 陈卫霞,闵鹏秋,宋彬,等.肝细胞癌螺旋CT同层动态扫描表现与肿瘤血管生成的相关性.中华放射学杂志,2001,35(4):247-252.
[14] Ippolito D,Sironi S,Pozzi M,et al.Hepatocellular carcinoma in cir-rhotic liver disease:functional computed tomography with perfusion imaging in the assessment of tumor vascularization.Acad Radiol,2008,15(7):919-927.
[15] Ippolito D,Capraro C,Casiraghi A,et al.Quantitative assessment of tumour associated neovascularisation in patients with liver ciirhosis and hepatocellular carcinoma:role of dynamic-CT perfusion imag-ing.Eur Radiol,2012,22(4):803-811.
[16] Li JP,Zhao DL,Jiang HJ,et al.Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.Hepatobiliary Pancreat Dis Int,2011,10(1):43-49.
[17] Yoo HJ,Lee JM,Lee JY,et al.Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellularcar cinoma in cirrhotic liver.Invest Radiol,2009,44(12):800-807.
[18] Chung J,Yu JS,Kim DJ,et al.Hypervascular hepatocellular carci-noma in the cirrhotic liver:diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.Magn Reson Imag-ing,2011,29(9):1235-1243.
[19] Park G,Kim YK,Kim CS,et al.Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas:comparison with gadopentetate dimeglumine.Br J Radiol,2010,83(996):1010-1016.
[20] Okada M,Imai Y,Kim T,et al.Comparison of enhancement pat-terns of histologically confirmed hepatocellular carcinoma between gadoxetate-and ferucarbotran-enhanced magnetic resonance imag-ing.J Magn Reson Imaging,2010,32(4):903-913.
[21] Xiao JD,Zhu W H,Shen SR.Evaluation of hepatocellular carci-noma using contrast-enhanced ultrasonography:correlation with microvessel morphology.Hepatobiliary Pancreat Dis Int,2010,9(6):605-610.
[22] Kim TK,Lee KH,Khalili K,et al.Hepatocellular nodules in liver cirrhosis:contrast-enhanced ultrasound.Abdom Imaging,2011,36(3):244-263.
[23] Gershtein ES,Dubova EA,Shchegolev Al,et al.Vascular endothe-lial growth factor and its type 2 receptor in hepatocellular carci-noma.Bull Exp Biol Med,2010,149(6):749-752.
[24] Siegel AB,Cohen El,Ocean A,et al.Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepa-tocellular carcinoma.J Clin Oncol,2008,26(18):2992-2998.
[25] Ong LC,Song IC,Jin Y,et al.Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.Mol Imaging Biol,2009,11(5):334-342.
[26] Backer MV,Levashova Z,Patel V,et al.Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes.Nat Med,2007,13(4):504-509.
[27] Cai W,Chen K,Mohamedali KA,et al.PET of vascular endothelial growth factor receptor expression.J Nucl Med,2006,47(12):2048-2056.
[28] Eder M,Krivoshein AV,Backer M,et al.ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates:comparison of easy-to-label recombinant proteins for[68Ga] PET imaging of VEGF receptors in angiogenic vasculature.Nucl Med Biol,2010,37(4):405-412.
[29] Beer AJ,Lorenzen S,Metz S,et al.Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients:a PET study using 18F-galacto-RGD and18F-FDG.J Nucl Med,2008,49(1):22-29.
[30] Cai H,Li Z,Huang CW,et al.64Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.Curr Radiopharm,2011,4(1):68-74.
[31] Namkoong S,Chung BH,Ha KS,et al.Microscopic technique for the detection of nitric oxide-dependent angiogenesis in an animal model.Methods Enzymol,2008,441:393-402.
[32] Li J,Stuhlmann H.In vitro imaging of angiogenesis using embry-onic stem cell-derived endothelial cells.Stem Cells Dev,2012,21(2):331-342.
[33] Liu X,Zhao J,Sun J,et al.Lung cancer and angiogenesis imaging using synchrotron radiation.Phys Med Biol,2010,55(8):2399-2409.
[34] Zhang L,Hu C,Zhao T,et al.Noninvasive visualization of microvessels using diffraction enhanced imaging.Eur J Radiol,2011,80(1):158-162.
[35] Li B,Xu M,Wu W,et al.In-line X-ray phase-contrast imaging of murine liver microvasculature ex vivo.Nucl Sci Tech,2012,23(1):10-14.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[3]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[4]戈畅,梁硕.化疗联合DC-CIK生物治疗非小细胞肺癌的临床价值及CT灌注成像的疗效评价[J].国际放射医学核医学杂志,2014,38(6):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
Ge Chang,Liang Shuo.The clinical value and CT perfusion evaluation in chemotherapy combined with DC-CIK biological treatment of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
[5]黄少祥,樊体强.塞来昔布对非小细胞肺癌移植瘤的辐射增敏实验研究[J].国际放射医学核医学杂志,2013,37(3):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
HUANG Shao-xiang,FAN Ti-qiang.Radiosensitization on non-small cell lung cancer induced by celecoxib[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
[6]龙再颖,汤春静,于立明,等.甲状腺乳头状癌术后刺激状态Tg与颈部淋巴结转移关系的研究[J].国际放射医学核医学杂志,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
LONG Zai-ying,TANG Chun-jing,YU Li-ming,et al.The correlation between the stimulated thyroglobulin level after surgery in papillary thyroid carcinoma and cervical lymph node metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
[7]于丽娟,李迎辞,王文志,等.PET-CT及PET-CT结合Lung VCAR软件对非小细胞肺癌肺门区淋巴结的诊断分析[J].国际放射医学核医学杂志,2012,36(6):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
YU Li-juan,LI Ying-ci,WANG Wen-zhi,et al.Value of PET-CT and PET-CT combined with Lung VCAR software in the diagnosis of hilar area lymph nodes of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
[8]刘莉,杨景魁.125I粒子植入治疗非小细胞肺癌的护理及辐射防护[J].国际放射医学核医学杂志,2012,36(3):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
LIU Li,YANG Jing-kui.Radiation protective nursing intervene of 125I seed implantation in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
[9]朱晓琳,李强.肝腺瘤的影像诊断现状及进展[J].国际放射医学核医学杂志,2011,35(2):124.[doi:10.3760/cma.j.issn.1673-4114.2011.02.014]
ZHU Xiao-lin,LI Qiang.Status and advances in imaging diagnsis of hepatic adenoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):124.[doi:10.3760/cma.j.issn.1673-4114.2011.02.014]
[10]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[11]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[12]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[13]李红兵,陈勇,曾建国,等.肝动脉化疗性栓塞结合Ⅱ期手术切除治疗巨块型外生型肝癌[J].国际放射医学核医学杂志,2010,34(1):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
LI Hong-bing,CHEN Yong,ZENG Jian-guo,et al.Treatment of massive extrahepatic growing hepatocellular carcinoma with TACE in combination with secondary resection[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
[14]郑磊,李前伟.18F-氟脱氧葡萄糖PET在原发陛肝细胞癌中的应用[J].国际放射医学核医学杂志,2008,32(1):23.
ZHENG Lei,LI Qian-wei.Application of positron emission tomography with 18F-fluorodeoxyglucose in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):23.
[15]周云,刘璐,宋进华.经肝动脉灌注90Y微球治疗肝癌的研究进展[J].国际放射医学核医学杂志,2006,30(6):321.
ZHOU Yun,LIU Lu,SONG Jin-hua.Clinical researched progress of intra-arterial radioembolization with 90Y-glass microspheres for treatment of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):321.
[16]麻广宇,刘家金,徐白萱,等.11C-乙酸盐PET/CT显像在中、高分化肝细胞肝癌复发与转移监测中的应用研究[J].国际放射医学核医学杂志,2018,(4):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
Ma Guangyu,Liu Jiajin,Xu Baixuan,et al.Application of 11C-acetate PET/CT imaging in the detection of recurrence and metastasis of hepatocellular carcinoma with intermediate and high differentiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
[17]赵竞,张占文,马慧,等.PET/CT显像剂18F-氟丙酸在肝癌中的生物学评估[J].国际放射医学核医学杂志,2018,(5):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
Zhao Jing,Zhang Zhanwen,Ma Hui,et al.Biological evaluation of PET/CT imaging agent 18F-fluoropropionic acid in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
[18]陈佩和,徐文贵,李小凤,等.肝细胞肝癌的葡萄糖代谢机制及在PET显像中的应用价值[J].国际放射医学核医学杂志,2018,(6):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]
Chen Peihe,Xu Wengui,Li Xiaofeng,et al.Glycometabolism mechanism in hepatocellular carcinoma and its application in PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]